These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 8348381

  • 1. Combined treatment with calcitonin and 1,25-dihydroxyvitamin D3 for osteoporosis in women.
    Eriksson SA, Lindgren JU.
    Calcif Tissue Int; 1993 Jul; 53(1):26-8. PubMed ID: 8348381
    [Abstract] [Full Text] [Related]

  • 2. Comparison of calcitriol treatment with etidronate-calcitriol and calcitonin-calcitriol combinations in Turkish women with postmenopausal osteoporosis: a prospective study.
    Gürlek A, Bayraktar M, Gedik O.
    Calcif Tissue Int; 1997 Jul; 61(1):39-43. PubMed ID: 9192511
    [Abstract] [Full Text] [Related]

  • 3. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E, Lyritis GP, Kosmidis C, Galanos A, Andypas G, Chorianopoulos K, Giagiosis A, Iliadou K, Karagianis A, Katsimichas K, Koskinas A, Matsouka K.
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [Abstract] [Full Text] [Related]

  • 4. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.
    Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, Eisman J.
    N Engl J Med; 1993 Jun 17; 328(24):1747-52. PubMed ID: 7684512
    [Abstract] [Full Text] [Related]

  • 5. Biochemical responses to sequential human parathyroid hormone (1-38) and calcitonin in osteoporotic patients.
    Hodsman AB, Fraher LJ.
    Bone Miner; 1990 May 17; 9(2):137-52. PubMed ID: 2161692
    [Abstract] [Full Text] [Related]

  • 6. The response to calcitriol therapy in postmenopausal osteoporotic women is a function of initial calcium absorptive status.
    Need AG, Morris HA, Horowitz M, Nordin BE.
    Calcif Tissue Int; 1997 Jul 17; 61(1):6-9. PubMed ID: 9192503
    [Abstract] [Full Text] [Related]

  • 7. A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial.
    Binkley N, Bolognese M, Sidorowicz-Bialynicka A, Vally T, Trout R, Miller C, Buben CE, Gilligan JP, Krause DS, Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) Investigators.
    J Bone Miner Res; 2012 Aug 17; 27(8):1821-9. PubMed ID: 22437792
    [Abstract] [Full Text] [Related]

  • 8. Early effect of nasal salmon calcitonin on the bone marker Crosslaps.
    Ofluoglu D, Karadag-Saygi E, Canbulat C, Gunduz OH, Kul-Panza E, Akyuz G.
    Rheumatol Int; 2006 Feb 17; 26(4):288-91. PubMed ID: 15875189
    [Abstract] [Full Text] [Related]

  • 9. Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study.
    Gonnelli S, Cepollaro C, Montomoli M, Gennari L, Montagnani A, Palmieri R, Gennari C.
    Clin Endocrinol (Oxf); 1997 Jan 17; 46(1):55-61. PubMed ID: 9059558
    [Abstract] [Full Text] [Related]

  • 10. Calcitonin.
    Silverman SL.
    Rheum Dis Clin North Am; 2001 Feb 17; 27(1):187-96. PubMed ID: 11285994
    [Abstract] [Full Text] [Related]

  • 11. Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate.
    Bianda T, Linka A, Junga G, Brunner H, Steinert H, Kiowski W, Schmid C.
    Calcif Tissue Int; 2000 Aug 17; 67(2):116-21. PubMed ID: 10920215
    [Abstract] [Full Text] [Related]

  • 12. Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients.
    Wang SX, Li H.
    Chin Med J (Engl); 2008 Jul 20; 121(14):1280-4. PubMed ID: 18713548
    [Abstract] [Full Text] [Related]

  • 13. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D.
    J Clin Endocrinol Metab; 1997 Feb 20; 82(2):620-8. PubMed ID: 9024265
    [Abstract] [Full Text] [Related]

  • 14. Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis.
    Plosker GL, McTavish D.
    Drugs Aging; 1996 May 20; 8(5):378-400. PubMed ID: 8935399
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effects of salmon calcitonin in treatment of osteoporosis in patients undergoing dialysis].
    Wang SX, Li H.
    Zhonghua Yi Xue Za Zhi; 2008 Feb 05; 88(6):387-90. PubMed ID: 18581891
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.
    Cosman F, Nieves J, Shen V, Lindsay R.
    J Bone Miner Res; 1995 Apr 05; 10(4):594-600. PubMed ID: 7610930
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.